Literature DB >> 9274432

Colorectal cancer--is there an alternative to 5-FU?

H Bleiberg1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274432     DOI: 10.1016/s0959-8049(96)00481-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  5 in total

Review 1.  Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer.

Authors:  F G Jansman; D T Sleijfer; J L Coenen; J C De Graaf; J R Brouwers
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

2.  Retrospective evaluation of 5-fluorouracil-interferon-a aTreatment of advanced colorectal cancer patients.

Authors:  C András; Z Csiki; I Gál; I Takács; L Antal; G Szegedi
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer.

Authors:  Gerrit Peters; Silvia Gongoll; Cord Langner; Michael Mengel; Pompiliu Piso; Jürgen Klempnauer; Josef Rüschoff; Hans Kreipe; Reinhard von Wasielewski
Journal:  Virchows Arch       Date:  2003-07-05       Impact factor: 4.064

Review 4.  The establishment of a large collaborative trial programme in the adjuvant treatment of colon cancer.

Authors:  J Wils
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

5.  Folate Conjugated Polyethylene Glycol Probe for Tumor-Targeted Drug Delivery of 5-Fluorouracil.

Authors:  Shabnam Sarwar; Muhammad Abdul Qadir; Rima D Alharthy; Mahmood Ahmed; Saghir Ahmad; Michiel Vanmeert; Muhammad Usman Mirza; Abdul Hameed
Journal:  Molecules       Date:  2022-03-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.